About the Editor-in-Chief

Dr. Mansoureh Nazari is a pharmaceutical scientist and R&D manager specializing in pharmacology, drug delivery systems, biotechnology, and natural product research. She holds a Ph.D. in Pharmaceutical Sciences (Pharmacology) from Universiti Sains Malaysia, where her doctoral work focused on developing and evaluating topical ethosomal formulations of Orthosiphon stamineus extract for melanoma treatment.

With over a decade of academic and industrial experience, Dr. Nazari has contributed significantly to drug development, nanotechnology-based delivery systems, and bioactive compound formulation. Her expertise extends across cancer research, anti-inflammatory and anti-angiogenic studies, and biopharmaceutical innovation.

Dr. Nazari has published extensively in high-impact international journals and holds multiple patents on novel formulations of Orthosiphon stamineus. Her research achievements have been recognized with gold and bronze medals at innovation exhibitions, including NiCeRs'18 and MTE 2019 in Kuala Lumpur.

Currently serving as R&D Manager at Takhsha Darou Behan Co. (Tehran, Iran) and Specialized Lecturer at the School of Pharmacy, University August 17, 1945 Jakarta, she combines academic mentorship with industrial research leadership. Dr. Nazari has also collaborated with companies such as Natureceuticals Sdn. Bhd., Eman Biodiscoveries, and Dexchem Industries in Malaysia, contributing to product development and commercialization in the biopharmaceutical sector.

Her long-term mission is to bridge the gap between academic innovation and industrial application, advancing global healthcare through evidence-based, sustainable, and technology-driven pharmaceutical solutions.